BEAM logo

Beam Therapeutics (BEAM) Cash From Operations

Annual CFO

-$149.19 M
-$171.72 M-762.29%

December 31, 2023


Summary


Performance

BEAM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBEAMcash flowmetrics:

Quarterly CFO

-$88.13 M
-$5.12 M-6.16%

September 30, 2024


Summary


Performance

BEAM Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBEAMcash flowmetrics:

TTM CFO

-$135.81 M
+$1.66 M+1.21%

September 30, 2024


Summary


Performance

BEAM TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherBEAMcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

BEAM Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-762.3%-6.2%+1.2%
3 y3 years-55.8%-3030.7%-47.0%
5 y5 years-635.0%-418.6%-88.6%

BEAM Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-762.3%at low-140.3%+19.8%-171.2%+61.6%
5 y5-year-762.3%at low-140.3%+19.8%-171.2%+61.6%
alltimeall time-762.3%at low-140.3%+19.8%-171.2%+61.6%

Beam Therapeutics Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$88.13 M(+6.2%)
-$135.81 M(-1.2%)
Jun 2024
-
-$83.01 M(-16.8%)
-$137.47 M(-1.2%)
Mar 2024
-
-$99.75 M(-173.8%)
-$139.13 M(-6.7%)
Dec 2023
-$149.19 M(-762.3%)
$135.07 M(-250.4%)
-$149.19 M(-57.8%)
Sep 2023
-
-$89.78 M(+6.0%)
-$353.46 M(+4.5%)
Jun 2023
-
-$84.67 M(-22.9%)
-$338.17 M(+10.6%)
Mar 2023
-
-$109.81 M(+58.7%)
-$305.78 M(-1457.4%)
Dec 2022
$22.53 M(-134.0%)
-$69.19 M(-7.1%)
$22.53 M(-75.9%)
Sep 2022
-
-$74.50 M(+42.5%)
$93.55 M(-45.3%)
Jun 2022
-
-$52.28 M(-123.9%)
$171.05 M(-10.4%)
Mar 2022
-
$218.49 M(>+9900.0%)
$190.80 M(-387.9%)
Dec 2021
-$66.27 M
$1.83 M(-39.1%)
-$66.27 M(-28.3%)
DateAnnualQuarterlyTTM
Sep 2021
-
$3.01 M(-109.2%)
-$92.40 M(-20.8%)
Jun 2021
-
-$32.53 M(-15.7%)
-$116.62 M(+9.1%)
Mar 2021
-
-$38.58 M(+58.8%)
-$106.93 M(+11.7%)
Dec 2020
-$95.74 M(+33.0%)
-$24.30 M(+14.5%)
-$95.74 M(+7.3%)
Sep 2020
-
-$21.21 M(-7.1%)
-$89.24 M(+5.0%)
Jun 2020
-
-$22.84 M(-16.6%)
-$85.02 M(+15.6%)
Mar 2020
-
-$27.39 M(+53.9%)
-$73.54 M(+2.1%)
Dec 2019
-$72.00 M(+254.7%)
-$17.80 M(+4.8%)
-$72.00 M(+32.8%)
Sep 2019
-
-$16.99 M(+49.7%)
-$54.20 M(+45.7%)
Jun 2019
-
-$11.35 M(-56.1%)
-$37.21 M(+43.9%)
Mar 2019
-
-$25.86 M
-$25.86 M
Dec 2018
-$20.30 M
-
-

FAQ

  • What is Beam Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Beam Therapeutics?
  • What is Beam Therapeutics annual CFO year-on-year change?
  • What is Beam Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Beam Therapeutics?
  • What is Beam Therapeutics quarterly CFO year-on-year change?
  • What is Beam Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Beam Therapeutics?
  • What is Beam Therapeutics TTM CFO year-on-year change?

What is Beam Therapeutics annual cash flow from operations?

The current annual CFO of BEAM is -$149.19 M

What is the all time high annual CFO for Beam Therapeutics?

Beam Therapeutics all-time high annual cash flow from operations is $22.53 M

What is Beam Therapeutics annual CFO year-on-year change?

Over the past year, BEAM annual cash flow from operations has changed by -$171.72 M (-762.29%)

What is Beam Therapeutics quarterly cash flow from operations?

The current quarterly CFO of BEAM is -$88.13 M

What is the all time high quarterly CFO for Beam Therapeutics?

Beam Therapeutics all-time high quarterly cash flow from operations is $218.49 M

What is Beam Therapeutics quarterly CFO year-on-year change?

Over the past year, BEAM quarterly cash flow from operations has changed by -$5.12 M (-6.16%)

What is Beam Therapeutics TTM cash flow from operations?

The current TTM CFO of BEAM is -$135.81 M

What is the all time high TTM CFO for Beam Therapeutics?

Beam Therapeutics all-time high TTM cash flow from operations is $190.80 M

What is Beam Therapeutics TTM CFO year-on-year change?

Over the past year, BEAM TTM cash flow from operations has changed by +$1.66 M (+1.21%)